MetaCap

SELLAS Life Sciences Group Insider Trades

NASDAQ: SLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.65+0.39 (+3.46%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $100.81K
Sales
0 · $0
Shares bought / sold
63.40K / 0
Net activity
Net buying $100,806

SELLAS Life Sciences Group insider activity

Over the last 12 months, SELLAS Life Sciences Group insiders reported 12 transactions on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $100,806 and sold $0 worth of stock, for net insider buying of $100,806. The most recent filing shows Stergiou Angelos M. (President and CEO) reporting a transaction in 1,065,000 shares on Jun 16, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SLS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

SLS insider transactions

SELLAS Life Sciences Group insider transactions
DateInsiderTypeSharesValueFiling
Jun 16, 2026Stergiou Angelos M.President and CEOAward1,065,000—Form 4
Jan 7, 2026Kalin Katherine BachDirectorAward50,000—Form 4
Jan 7, 2026Burns John ThomasCFOAward300,000—Form 4
Jan 7, 2026SCHEINBERG DAVID ADirectorAward50,000—Form 4
Jan 7, 2026Wasman JaneDirectorAward50,000—Form 4
Jan 7, 2026Varian JohnDirectorAward50,000—Form 4
Jan 7, 2026VAN NOSTRAND ROBERT LDirectorAward50,000—Form 4
Jan 7, 2026CICIC DRAGANSVP, Chief Development OfficerAward300,000—Form 4
Dec 3, 2025Stergiou Angelos M.President and CEOother187,066$280.60KForm 4
Dec 3, 2025Burns John ThomasCFOother58,592$87.89KForm 4
Dec 3, 2025CICIC DRAGANSVP, Chief Development Officerother63,800$95.70KForm 4
Nov 19, 2025Kalin Katherine BachDirectorBuy63,400$100.81KForm 4
Jun 12, 2025VAN NOSTRAND ROBERT LDirectorBuy10,000$14.80KForm 4
May 30, 2025Wasman JaneDirectorBuy20,000$33.80KForm 4
May 22, 2025Kalin Katherine BachDirectorBuy20,000$36.00KForm 4
Jan 10, 2025CICIC DRAGANSVP, Chief Development OfficerAward81,300—Form 4
Jan 10, 2025CICIC DRAGANSVP, Chief Development OfficerAward113,000—Form 4
Jan 10, 2025Kalin Katherine BachDirectorAward12,500—Form 4
Jan 10, 2025VAN NOSTRAND ROBERT LDirectorAward12,500—Form 4
Jan 10, 2025Varian JohnDirectorAward12,500—Form 4
Jan 10, 2025SCHEINBERG DAVID ADirectorAward12,500—Form 4
Jan 10, 2025Stergiou Angelos M.President and CEOAward243,900—Form 4
Jan 10, 2025Stergiou Angelos M.President and CEOAward257,000—Form 4
Jan 10, 2025Burns John ThomasCFOAward81,300—Form 4
Jan 10, 2025Burns John ThomasCFOAward113,000—Form 4
Jan 10, 2025Wasman JaneDirectorAward12,500—Form 4
Dec 4, 2024Stergiou Angelos M.President and CEOother28,289$31.97KForm 4
Dec 4, 2024Burns John ThomasCFOother7,165$8.10KForm 4
Dec 4, 2024CICIC DRAGANSVP, Chief Development Officerother8,256$9.33KForm 4
Jan 22, 2024Burns John ThomasCFOAward47,000—Form 4
Jan 22, 2024VAN NOSTRAND ROBERT LDirectorAward6,000—Form 4
Jan 22, 2024Varian JohnDirectorAward6,000—Form 4
Jan 22, 2024Francomano RobertChief Commercial OfficerAward20,000—Form 4
Jan 22, 2024Wasman JaneDirectorAward6,000—Form 4
Jan 22, 2024Kalin Katherine BachDirectorAward6,000—Form 4
Jan 22, 2024SCHEINBERG DAVID ADirectorAward6,000—Form 4
Jan 22, 2024Stergiou Angelos M.President and CEOAward159,000—Form 4
Jan 22, 2024WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.Award35,000—Form 4
Dec 6, 2023Burns John ThomasCFOother2,929$3.16KForm 4
Dec 6, 2023Stergiou Angelos M.President and CEOother12,268$13.25KForm 4
Dec 6, 2023Francomano RobertChief Commercial Officerother1,082$1.17KForm 4
Dec 6, 2023WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.other4,119$4.45KForm 4
Feb 2, 2023WOOD BARBARA AEVP, Gen. Counsel, Corp. Sec.Award20,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related